rs4342

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000789.4(ACE):​c.2306-11A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.48 in 1,456,736 control chromosomes in the GnomAD database, including 170,558 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 14514 hom., cov: 25)
Exomes 𝑓: 0.48 ( 170558 hom. )
Failed GnomAD Quality Control

Consequence

ACE
NM_000789.4 intron

Scores

2
Splicing: ADA: 0.00004375
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.517

Publications

23 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 17-63488637-A-C is Benign according to our data. Variant chr17-63488637-A-C is described in ClinVar as Benign. ClinVar VariationId is 256801.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.642 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACENM_000789.4 linkc.2306-11A>C intron_variant Intron 15 of 24 ENST00000290866.10 NP_000780.1 P12821-1B4DKH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACEENST00000290866.10 linkc.2306-11A>C intron_variant Intron 15 of 24 1 NM_000789.4 ENSP00000290866.4 P12821-1
ENSG00000264813ENST00000577647.2 linkn.584-11A>C intron_variant Intron 4 of 30 2 ENSP00000464149.1 F6X3S4

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
63346
AN:
142168
Hom.:
14490
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.393
Gnomad AMI
AF:
0.392
Gnomad AMR
AF:
0.496
Gnomad ASJ
AF:
0.359
Gnomad EAS
AF:
0.644
Gnomad SAS
AF:
0.568
Gnomad FIN
AF:
0.415
Gnomad MID
AF:
0.309
Gnomad NFE
AF:
0.455
Gnomad OTH
AF:
0.408
GnomAD2 exomes
AF:
0.501
AC:
125876
AN:
251102
AF XY:
0.500
show subpopulations
Gnomad AFR exome
AF:
0.413
Gnomad AMR exome
AF:
0.582
Gnomad ASJ exome
AF:
0.364
Gnomad EAS exome
AF:
0.668
Gnomad FIN exome
AF:
0.442
Gnomad NFE exome
AF:
0.465
Gnomad OTH exome
AF:
0.473
GnomAD4 exome
AF:
0.480
AC:
699526
AN:
1456736
Hom.:
170558
Cov.:
41
AF XY:
0.481
AC XY:
348995
AN XY:
724934
show subpopulations
African (AFR)
AF:
0.409
AC:
13652
AN:
33412
American (AMR)
AF:
0.575
AC:
25687
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
9502
AN:
26100
East Asian (EAS)
AF:
0.649
AC:
25720
AN:
39650
South Asian (SAS)
AF:
0.580
AC:
49970
AN:
86134
European-Finnish (FIN)
AF:
0.444
AC:
23603
AN:
53164
Middle Eastern (MID)
AF:
0.362
AC:
2086
AN:
5756
European-Non Finnish (NFE)
AF:
0.470
AC:
520859
AN:
1107592
Other (OTH)
AF:
0.472
AC:
28447
AN:
60226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
20709
41419
62128
82838
103547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15604
31208
46812
62416
78020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.446
AC:
63402
AN:
142276
Hom.:
14514
Cov.:
25
AF XY:
0.445
AC XY:
30711
AN XY:
69082
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.392
AC:
15098
AN:
38476
American (AMR)
AF:
0.497
AC:
6937
AN:
13970
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
1211
AN:
3370
East Asian (EAS)
AF:
0.645
AC:
2987
AN:
4632
South Asian (SAS)
AF:
0.569
AC:
2448
AN:
4302
European-Finnish (FIN)
AF:
0.415
AC:
3964
AN:
9554
Middle Eastern (MID)
AF:
0.305
AC:
86
AN:
282
European-Non Finnish (NFE)
AF:
0.455
AC:
29496
AN:
64812
Other (OTH)
AF:
0.415
AC:
839
AN:
2020
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.366
Heterozygous variant carriers
0
1593
3185
4778
6370
7963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.441
Hom.:
4297
Bravo
AF:
0.462

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Renal tubular dysgenesis Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.1
DANN
Benign
0.54
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000044
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4342; hg19: chr17-61565998; API